Beta Bionics (BBNX) Inventory (2023 - 2026)

Beta Bionics has disclosed Inventory across 4 years of filings, most recently posting $23.9 million for Q2 2026.

• In Q2 2026, Inventory rose 38.07% year-over-year to $23.9 million; the TTM figure through Jun 2026 stood at $23.9 million (up 38.07% YoY), while the FY2025 annual figure was $21.7 million, up 63.08% from the prior year.
• Inventory came in at $23.9 million for Q2 2026 at Beta Bionics, up from $23.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.9 million in Q2 2026 to a low of $1.2 million in Q4 2023.
• Average Inventory over 4 years is $17.2 million, with a median of $18.8 million recorded in 2025.
• Year-over-year, Inventory soared 969.88% in 2024 and soared 38.07% in 2026.
• Over 4 years, Inventory stood at $1.2 million in 2023, then soared by 969.88% to $13.3 million in 2024, then surged by 63.08% to $21.7 million in 2025, then climbed by 10.11% to $23.9 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $23.9 million in Q2 2026, $23.7 million in Q1 2026, and $21.7 million in Q4 2025.